Page last updated: 2024-10-29

indomethacin and Neurally Mediated Faint

indomethacin has been researched along with Neurally Mediated Faint in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lewis, NC1
Bain, AR1
MacLeod, DB1
Wildfong, KW1
Smith, KJ1
Willie, CK1
Sanders, ML1
Numan, T1
Morrison, SA1
Foster, GE1
Stewart, JM1
Ainslie, PN1

Trials

1 trial available for indomethacin and Neurally Mediated Faint

ArticleYear
Impact of hypocapnia and cerebral perfusion on orthostatic tolerance.
    The Journal of physiology, 2014, Dec-01, Volume: 592, Issue:23

    Topics: Adult; Cerebrovascular Circulation; Cyclooxygenase Inhibitors; Female; Homeostasis; Humans; Hyperven

2014